Latest News and Press Releases
Want to stay updated on the latest news?
-
DELHI, India, July 16, 2021 (GLOBE NEWSWIRE) -- Gamma Delta T Cell Cancer Therapy Opportunity & Clinical Trials Insight 2026” Report Highlights: Commercialization Market Potential After Market...
-
DELHI, India, July 06, 2021 (GLOBE NEWSWIRE) -- Global Peptide Drug Conjugate Market & Clinical Trials Insight 2026 Report Highlights: First FDA Approved Peptide Drug Conjugate: Pepaxto...
-
DELHI, India, April 23, 2021 (GLOBE NEWSWIRE) -- “Gamma Delta T Cell Cancer Therapy Opportunity & Clinical Trials Insight 2026” Report Highlights: Commercialization Market...
-
DELHI, India, April 22, 2021 (GLOBE NEWSWIRE) -- “Global Peptide Cancer Vaccine Market & Clinical Trials Insight 2026” Report Highlights: Global Peptide Cancer Vaccine Market Trends...
-
DELHI, India, April 17, 2021 (GLOBE NEWSWIRE) -- “Global C5 Complement Inhibitors Drug Market Opportunity, Drug Price, Sales & Clinical Trials Insight 2026” Report Highlights: Global C5...
-
DELHI, India, April 17, 2021 (GLOBE NEWSWIRE) -- “Global C5 Compliment Inhibitors Drug Market Opportunity, Drug Price, Sales & Clinical Trials Insight 2026” Report Highlights: Global C5...
-
DELHI, India, April 17, 2021 (GLOBE NEWSWIRE) -- “Global Anaplastic Lymphoma Kinase ALK Inhibitors Market & Clinical Trials Insight 2026” Report Highlights: Global ALK Inhibitors Market...
-
DELHI, India, April 17, 2021 (GLOBE NEWSWIRE) -- Global Peptide Drug Conjugate Market and Clinical Trials Insight 2026 Report Highlights: First FDA Approved Peptide Drug Conjugate: Pepaxto...
-
Global Peptide Cancer Therapeutics Market Will Be Driven By Improving Clinical Trial Landscape And Entry Of New Product In The Market Ay Kuick Research DELHI, India, March 11, 2021 (GLOBE NEWSWIRE)...
-
US Cancer Biosimilar Market Size Sales Opportunity Oncology Biosimilars Clinical Trials Outlook 2026
DELHI, India, March 08, 2021 (GLOBE NEWSWIRE) -- "US Cancer Biosimilar Market Opportunity, Drug Dosage, Price & Clinical Trials Insight 2026" Report highlights: US Cancer Biosimilar Market...